The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages 193-200

  Petta, Salvatore ^a   Grimaudo, Stefania ^a   Tripodo, Claudio ^b   Cabibi, Daniela ^b   Calvaruso, Marco ^b   Di Cristina, Antonietta ^a   Guarnotta, Carla ^b   Macaluso, Fabio Salvatore ^a   Minissale, Maria Giovanna ^a   Marchesini, Giulio ^c   Craxì, Antonio ^a  

^a Divisione Medicina Interna e Specialistica   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CELLS BY BODY ANATOMY; CHOLANGIOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; FEMALE; GENOTYPE 1 CHRONIC HEPATITIS C; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STRUCTURE ANALYSIS; WESTERN BLOTTING; CHRONIC HEPATITIS C; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

HEPATITIS C VIRUS;

ADULT; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RECEPTORS, CALCITRIOL; SEVERITY OF ILLNESS INDEX;

EID: 84920587029     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2741     Document Type: Article

References (28)

1. Herzer K, Sprinzl MF, Galle PR. Hepatitis viruses: live and let die. Liver Int. 2007;27:293-301.
2. Petta S,Cammá C,Di Marco V,et al. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection Antivir Ther. 2009 14 631-639.
3. Romero-Gó mez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology. 2005;128: 636-641.
4. Petta S, Macaluso FS, Cammá C, Marco VD, Cabibi D, Craxí A. Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. Liver Int. 2012;32: 1443-1450.
5. Villa E, Vukotic R,Cammá C, et al. Reproductive status is associated with the severity of fibrosis in women with hepatitis C. PLoS One. 2012;7(9):e44624.
6. Petta S, Cammá C, Scazzone C, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51: 1158-1167.
7. Petta S, Grimaudo S, Di Marco V, et al. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Vi ral Hepat. 2013;20:486-493.
8. Baur K, Mertens JC, Schmitt J, et al. Swiss HepatitisCCohort Study Group. Combined effect of 25-OH vitamin D plasma levels and genetic vitaminDreceptor (NR 1I1) variant s on fibrosis progression rate in HCV patients. Liver Int. 2012;32:635-643.
9. Lange CM, Bojunga J, Ramos-Lopez E, et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-Alfa based therapy. J Hepatol. 2011;54:887-893.
10. Kitson MT, Dore GJ, George J, et al. Vitamin D status does not predict sustained viro logic response or fibrosis stage in chronic hepatitis C genotype 1 infection. J Hepatol. 2013;58:467-472.
11. Falleti E, Bitetto D, Fabris C, et al. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology. 2012;56:1641-1650.
12. Baur K, Mertens JC, Schmitt J, et al. Swiss HepatitisCCohort Study Gr oup. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients. Antivir Ther. 2012;17:541-547.
13. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376:180-188.
14. Moore DD, Kato S, Xie W, et al. International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor-, farnesoidXreceptor-, liverXreceptor-, liverXreceptor-, and vitamin D receptor. Pharmacol Rev. 2006;58:742-759.
15. Abramovitch S, Dahan-Bachar L, Sharvit E, et al. VitaminDinhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats . Gut. 2011;60:1728-1737.
16. Roth CL, Elfers CT, Figlewicz DP, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-lik e receptor activation. Hepatology. 2012; 55:1103-1111.
17. Hennes EM, Zeniya M, Czaja AJ Parés A, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48: 169-176.
18. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classi fication of Diabetes Mellitus. American Diabetes Association: Clinical Practice Recommendations 2000 Committee Report. Diabetes Care. 2000;23:S4-S19.
19. Matthews DR, Hosker JP, Rudenski AS, Nayl or BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
20. I keda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J. 2001;48:81-86.
21. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol. 2003;39:239-244.
22. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13:372-374.
23. SAS Technical Report. SAS/STAT software: changes and enhancement release 6.07. Cary NC:
24. Barchetta I, Carotti S, Labbadia G, et al. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcohol ic steatohepatitis or hepatitis C virus. Hepatology. 2012;56:2180-2187.
25. Von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor si gnaling and activation of human T cells. Nat Immunol. 2010;11:344-349.
26. Grappone C, Pinzani M, Parola M, et al. Expression of plateletderived growth factor in newly formed cholangiocytes duri ng experimental biliary fibrosis in rats. J Hepatol. 1999;31:100-109.
27. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tu mor necrosis factor-in pathologic biliary epithelial cells: in situ and culture study. Lab Invest. 1998;78:89-100.
28. Vespasiani-Gentilucci U, Carotti S, Onetti-Muda A, et al. Toll-like recept or-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease. Mod Pathol. 2012; 25:576-589.